Errata: Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM)

DOI:

10.3791/5755

⸱

Non Pubblicato

In questo articolo

Sommario

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM).

Abstract

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM). The disclosures were updated.

Protocollo

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM). The disclosures were updated from:

David Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. PeriRx LLC sublicensed intellectual properties pertaining to molecular diagnostics from RNAmeTRIX. David Wong is a consultant to PeriRx.

to

David T. Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. He holds equity in RNAmeTRIX, and serves as a company director and scientific advisor. The University of California also holds equity in RNAmeTRIX. Intellectual property that David T. Wong invented and which was patented by the University of California has been licensed to RNAmeTRIX. Additionally, he is a paid consultant to PeriRx.

Dichiarazioni

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
No conflicts of interest declared.

Ristampe e permessi

Richiedi il permesso di riutilizzare il testo o le figure di questo articolo JoVE

Richiedi permesso

Tag

Rilevamento di biomarcatorianalisi degli esosomiapplicazione di campi elettricimisurazione di biomarcatoririlascio di esosomimetodo di rilevamentoanalisi di biomarcatori